HomeGrants › RFA-AR-26-006

Forecasted

Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0

Federal funding opportunity RFA-AR-26-006 from National Institutes of Health.

View forecast on Grants.gov →Forecasted — not yet open

Posted
January 22, 2026
Closes
See announcement
Expected awards
8
Cost sharing
No
Instrument
Cooperative Agreement
Assistance listing
93.846
Category
Health

Program funding history

Awards made under Assistance Listing 93.846 across FY2024–FY2026, from public federal spending records.

FY2024 obligated
$535.2M
FY2025 obligated
$537.1M
FY2026 (to date) obligated
$251.2M
Awards in window
2,932

Top recipients: Trustees of the University of Pennsylvania, the, Regents of the University of California, San Francisco, the, Brigham & Womens Hospital Inc, Regents of the University of Michigan, The General Hospital Corporation

Source: USAspending.gov · refreshed July 2026

Synopsis

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), in conjunction with other NIH Institutes and Centers (ICs) as a part of the congressionally mandated NIH Helping to End Addiction Long Term (HEAL) initiative intends to publish a Notice of Funding Opportunity (NOFO) to leverage and accelerate the progress achieved in the Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium.

The NOFO aims to more fully refine and map the innervation of the different articular and peri-articular tissues that collectively form the joint (including bone, cartilage, synovium, joint capsule, ligament, tendon, fascia and muscle), by sensory neurons that mediate the sensation of pain.

The NOFO seeks to expand initial and ongoing efforts by:

  • Enhancing clinical pain phenotyping with multimodal profiling of new and expanded patient samples across life span and disease conditions (i.e., other musculoskeletal and/or rheumatic conditions associated with joint pain beyond knee and temporomandibular joint (TMJ)).
  • Expanding to new preclinical and New Approach Methodologies (NAMs) in modeling joint disease.
  • Preclinical testing of novel joint-targeted candidates identified in RE-JOIN 1.0.
  • Focusing on peri-articular tissues in joint pain, such as vasculature, synovium, adipose, myofascial tissue, etc.
  • Prioritizing secondary analysis of datasets and/or validation of methods and approaches in human samples.
  • Improve data integration by developing/enhancing joint atlases that will enable integration of imaging and molecular datasets.

Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful multidisciplinary collaborations and responsive projects. Investigators with expertise and insights in neurobiology, pain science, data science, orthopedics, rheumatic disease, etc. are encouraged to consider applying for this NOFO.

Who can apply

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

How to apply

Applications go through the official government listing. Grants Radar links you straight to the source.

View on Grants.gov

Agency contact: National Institute of Arthritis and Musculoskeletal and Skin Diseases · NIAMS_PAIN@mail.nih.gov · Please contact via e-mail.

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.

The free edition carries one clearly labeled sponsor slot. No spam, ever. Privacy

Similar grants

Never miss a funding deadline again

Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.

Get funding alerts